Ryman Healthcare Valuation Multiples

Discover revenue and EBITDA valuation multiples for Ryman Healthcare and similar public comparables like Summerset Group Holdings, Omada Health, Ship Healthcare Holdings, Ambea and more.

Ryman Healthcare Overview

About Ryman Healthcare

Ryman Healthcare Ltd develops, owns, and operates retirement villages and aged-care facilities in New Zealand and Australia. Its villages offer a combination of independent and serviced units, alongside hospital, dementia, and rest-home care. Income is predominantly earned from aged care fees, retirement unit management fees, development margins on new units, and capital gains generated when residents vacate and Ryman resells existing units.


Founded

1984

HQ

New Zealand

Employees

150

Financials (LTM)

Revenue: $505M
EBITDA: $40M

EV

$2.2B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Ryman Healthcare Financials

Ryman Healthcare reported last 12-month revenue of $505M and EBITDA of $40M.

In the same LTM period, Ryman Healthcare generated $40M in EBITDA and $11M in net income.

Revenue (LTM)


Ryman Healthcare P&L

In the most recent fiscal year, Ryman Healthcare reported revenue of $473M and EBITDA of ($33M).

Ryman Healthcare is unprofitable as of last fiscal year, with gross margin of 100%, EBITDA margin of (7%), and net margin of (21%).

See analyst estimates for Ryman Healthcare
LTMLast FY202320242025202620272028
Revenue$505M$473M$370M$411M$460M
Gross Profit-$473M$370M$411M$421M
Gross Margin-100%100%100%92%
EBITDA$40M($33M)$45M($19M)$17M
EBITDA Margin8%(7%)12%(5%)4%
EBIT Margin16%(2%)(9%)(15%)5%
Net Profit$11M($102M)$40M($192M)($84M)
Net Margin2%(21%)11%(47%)(18%)
Net Debt-$4.6B---

Financial data powered by Morningstar, Inc.

Ryman Healthcare Stock Performance

Ryman Healthcare has current market cap of $1.2B, and enterprise value of $2.2B.

Market Cap Evolution


Ryman Healthcare's stock price is $1.22.

Ryman Healthcare share price decreased by 1.8% in the last 30 days, and by 18.5% in the last year.

Ryman Healthcare has an EPS (earnings per share) of $-0.10.

See more trading valuation data for Ryman Healthcare
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$2.2B$1.2B1.9%-1.8%-4.4%-18.5%$-0.10

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Ryman Healthcare Valuation Multiples

Ryman Healthcare trades at 4.4x EV/Revenue multiple, and 55.5x EV/EBITDA.

See NTM and 2027E valuation multiples for Ryman Healthcare

EV / Revenue (LTM)


Ryman Healthcare Financial Valuation Multiples

As of September 5, 2026, Ryman Healthcare has market cap of $1.2B and EV of $2.2B.

Ryman Healthcare has a P/E ratio of 111.6x.

LTMLast FY202320242025202620272028
EV/Revenue4.4x4.7x6.0x5.4x4.8x
EV/EBITDA55.5x(67.9x)49.4x(114.3x)133.8x
EV/EBIT27.2x(211.6x)(66.1x)(35.6x)105.2x
EV/Gross Profit-4.7x6.0x5.4x5.3x
P/E111.6x(12.2x)31.0x(6.5x)(14.9x)
EV/FCF22.6x13.1x8.5x10.8x16.3x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Ryman Healthcare Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Ryman Healthcare Margins & Growth Rates

Ryman Healthcare grew revenue by 16% but EBITDA decreased by 272% in the last fiscal year.

In the most recent fiscal year, Ryman Healthcare reported gross margin of 100%, EBITDA margin of (7%), and net margin of (21%).

See estimated margins and future growth rates for Ryman Healthcare

Ryman Healthcare Margins

Last FY202420252026202720282029
Gross Margin100%100%92%-
EBITDA Margin(7%)(5%)4%9%
EBIT Margin(2%)(15%)5%20%
Net Margin(21%)(47%)(18%)7%
FCF Margin36%50%30%15%

Ryman Healthcare Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth16%11%12%15%
Gross Profit Growth-11%2%-
EBITDA Growth(272%)(143%)(185%)196%
EBIT Growth(1260%)86%(134%)393%
Net Profit Growth(159%)(580%)(57%)(146%)
FCF Growth(60%)(22%)(34%)(40%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Ryman Healthcare Operational KPIs

Ryman Healthcare's revenue per employee in the last FY averaged $3.2M, while opex per employee averaged $3.2M for the same period.

Ryman Healthcare's Rule of 40 is 24% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Ryman Healthcare's Rule of X is 47% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Ryman Healthcare
LTMLast FY202320242025202620272028
Rule of 4020%24%---
Bessemer Rule of X37%47%---
Revenue per Employee-$3.2M---
Opex per Employee-$3.2M---
S&M Expenses to Revenue-3%8%5%4%
G&A Expenses to Revenue-4%66%70%66%
Opex to Revenue-102%109%115%107%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Ryman Healthcare Competitors

Ryman Healthcare competitors include Summerset Group Holdings, Omada Health, Ship Healthcare Holdings, Ambea, InnovAge, Regis Healthcare, Healthcare Services Group, Sienna Senior Living, Clariane and Enhabit.

Most Ryman Healthcare public comparables operate across Long-Term Care.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Summerset Group Holdings21.4x15.3x39.9x28.0x
Omada Health4.5x3.7x(116.6x)59.4x
Ship Healthcare Holdings0.2x0.2x5.4x5.2x
Ambea1.7x1.5x9.5x8.3x
InnovAge1.7x1.5x(145.9x)16.1x
Regis Healthcare0.9x0.9x4.1x8.7x
Healthcare Services Group0.7x0.7x15.7x10.9x
Sienna Senior Living3.5x3.1x21.9x18.3x

This data is available for Pro users. Sign up to see all Ryman Healthcare competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Ryman Healthcare

When was Ryman Healthcare founded?Ryman Healthcare was founded in 1984.
Where is Ryman Healthcare headquartered?Ryman Healthcare is headquartered in New Zealand.
How many employees does Ryman Healthcare have?As of today, Ryman Healthcare has over 150 employees.
Is Ryman Healthcare publicly listed?Yes, Ryman Healthcare is a public company listed on New Zealand Exchange.
What is the stock symbol of Ryman Healthcare?Ryman Healthcare trades under RYM ticker.
When did Ryman Healthcare go public?Ryman Healthcare went public in 1999.
Who are competitors of Ryman Healthcare?Ryman Healthcare main competitors include Summerset Group Holdings, Omada Health, Ship Healthcare Holdings, Ambea, InnovAge, Regis Healthcare, Healthcare Services Group, Sienna Senior Living, Clariane, Enhabit.
What is the current market cap of Ryman Healthcare?Ryman Healthcare's current market cap is $1.2B.
What is the current revenue of Ryman Healthcare?Ryman Healthcare's last 12 months revenue is $505M.
What is the current revenue growth of Ryman Healthcare?Ryman Healthcare revenue growth (NTM/LTM) is 12%.
What is the current EV/Revenue multiple of Ryman Healthcare?Current revenue multiple of Ryman Healthcare is 4.4x.
What is the current EBITDA of Ryman Healthcare?Ryman Healthcare's last 12 months EBITDA is $40M.
What is Ryman Healthcare's EBITDA margin?Ryman Healthcare's last 12 months EBITDA margin is 8%.
What is the current EV/EBITDA multiple of Ryman Healthcare?Current EBITDA multiple of Ryman Healthcare is 55.5x.
What is the current FCF of Ryman Healthcare?Ryman Healthcare's last 12 months FCF is $99M.
What is Ryman Healthcare's FCF margin?Ryman Healthcare's last 12 months FCF margin is 20%.
What is the current EV/FCF multiple of Ryman Healthcare?Current FCF multiple of Ryman Healthcare is 22.6x.
How many companies Ryman Healthcare has acquired to date?Ryman Healthcare hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Ryman Healthcare has invested to date?Ryman Healthcare hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Ryman Healthcare

Lists including Ryman Healthcare

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial